Literature DB >> 20876254

Targeting hypoxic cells through the DNA damage response.

Monica Olcina1, Philip S Lecane, Ester M Hammond.   

Abstract

Exposure to hypoxia-induced replication arrest initiates a DNA damage response that includes both ATR- and ATM-mediated signaling. DNA fiber analysis was used to show that these conditions lead to a replication arrest during both the initiation and elongation phases, and that this correlated with decreased levels of nucleotides. The DNA damage response induced by hypoxia is distinct from the classical pathways induced by damaging agents, primarily due to the lack of detectable DNA damage, but also due to the coincident repression of DNA repair in hypoxic conditions. The principle aims of the hypoxia-induced DNA damage response seem to be the induction of p53-dependent apoptosis or the preservation of replication fork integrity. The latter is of particular importance should reoxygenation occur. Tumor reoxygenation occurs as a result of spontaneous changes in blood flow and also therapy. Cells experiencing hypoxia and/or reoxygenation are, therefore, sensitive to loss or inhibition of components of the DNA damage response, including Chk1, ATM, ATR, and poly(ADP-ribose) polymerase (PARP). In addition, restoration of hypoxia-induced p53-mediated signaling may well be effective in the targeting of hypoxic cells. The DNA damage response is also induced in endothelial cells at moderate levels of hypoxia, which do not induce replication arrest. In this situation, phosphorylation of H2AX has been shown to be required for proliferation and angiogenesis and is, therefore, an attractive potential therapeutic target. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876254      PMCID: PMC3000384          DOI: 10.1158/1078-0432.CCR-10-0286

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  60 in total

Review 1.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

Review 2.  Oxygen sensing and the DNA-damage response.

Authors:  Ester M Hammond; Muriel R Kaufmann; Amato J Giaccia
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

3.  Hypoxia and Radiation Response in Human Tumors.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1996-01       Impact factor: 5.934

4.  Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line.

Authors:  J Bussink; J H Kaanders; P F Rijken; J A Raleigh; A J Van der Kogel
Journal:  Radiat Res       Date:  2000-04       Impact factor: 2.841

Review 5.  "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways.

Authors:  Constantinos Koumenis; Bradly G Wouters
Journal:  Mol Cancer Res       Date:  2006-07       Impact factor: 5.852

Review 6.  Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

Authors:  Robert G Bristow; Richard P Hill
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

7.  Histone H2AX is integral to hypoxia-driven neovascularization.

Authors:  Matina Economopoulou; Harald F Langer; Arkady Celeste; Valeria V Orlova; Eun Young Choi; Mingchao Ma; Athanassios Vassilopoulos; Elsa Callen; Chuxia Deng; Craig H Bassing; Manfred Boehm; Andre Nussenzweig; Triantafyllos Chavakis
Journal:  Nat Med       Date:  2009-04-19       Impact factor: 53.440

Review 8.  Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment.

Authors:  Rob Cairns; Ioanna Papandreou; Nicholas Denko
Journal:  Mol Cancer Res       Date:  2006-02       Impact factor: 5.852

Review 9.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

10.  ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling.

Authors:  Thomas Stiff; Sarah A Walker; Karen Cerosaletti; Aaron A Goodarzi; Eva Petermann; Pat Concannon; Mark O'Driscoll; Penny A Jeggo
Journal:  EMBO J       Date:  2006-11-23       Impact factor: 11.598

View more
  43 in total

Review 1.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

2.  EGFR Mutations Compromise Hypoxia-Associated Radiation Resistance through Impaired Replication Fork-Associated DNA Damage Repair.

Authors:  Mohammad Saki; Haruhiko Makino; Prashanthi Javvadi; Nozomi Tomimatsu; Liang-Hao Ding; Jennifer E Clark; Elaine Gavin; Kenichi Takeda; Joel Andrews; Debabrata Saha; Michael D Story; Sandeep Burma; Chaitanya S Nirodi
Journal:  Mol Cancer Res       Date:  2017-08-11       Impact factor: 5.852

3.  Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue.

Authors:  Weidong Wang; Jinyi Lang
Journal:  Exp Ther Med       Date:  2012-05-30       Impact factor: 2.447

Review 4.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.

Authors:  Yosef Shiloh; Yael Ziv
Journal:  Nat Rev Mol Cell Biol       Date:  2013-03-13       Impact factor: 94.444

Review 5.  Targeting hypoxia in cancer therapy.

Authors:  William R Wilson; Michael P Hay
Journal:  Nat Rev Cancer       Date:  2011-06       Impact factor: 60.716

Review 6.  HPV, hypoxia and radiation response in head and neck cancer.

Authors:  Eva-Leonne Göttgens; Christian Ostheimer; Paul N Span; Jan Bussink; Ester M Hammond
Journal:  Br J Radiol       Date:  2018-03-14       Impact factor: 3.039

Review 7.  Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia.

Authors:  Annamaria Rapisarda; Giovanni Melillo
Journal:  Nat Rev Clin Oncol       Date:  2012-04-24       Impact factor: 66.675

8.  Hypoxia-induced alterations of G2 checkpoint regulators.

Authors:  Grete Hasvold; Christin Lund-Andersen; Malin Lando; Sebastian Patzke; Sissel Hauge; ZhenHe Suo; Heidi Lyng; Randi G Syljuåsen
Journal:  Mol Oncol       Date:  2016-01-08       Impact factor: 6.603

9.  LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation.

Authors:  Hua Mao; Pamela Lockyer; W H Davin Townley-Tilson; Liang Xie; Xinchun Pi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-03       Impact factor: 8.311

Review 10.  ATR/CHK1 inhibitors and cancer therapy.

Authors:  Zhaojun Qiu; Nancy L Oleinick; Junran Zhang
Journal:  Radiother Oncol       Date:  2017-10-18       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.